Vivo Capital VIII LLC 13D and 13G filings for Agile Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2020-02-13 5:10 pm Sale | 2019-12-31 | 13G | Agile Therapeutics, Inc. AGRX | Vivo Capital VIII LLC | 95 0.300% | -662![]() (-87.50%) | Filing |